Ginkgo Bioworks Holdings, Inc. (DNA)
Ginkgo Bioworks Holdings, Inc. (DNA) has a 18-report earnings history dating back to Nov 15, 2021. Its average absolute post-earnings move is ±11.58%, and 38.9% of those reactions were positive. Its largest post-earnings gain was +22.73% (Mar 28, 2022) and its largest decline was -30.48% (Feb 26, 2026). The next earnings report is predicted for 2026-08-12 (approximate).
Earnings reactions
How DNA moved on each past earnings report.
Earnings Impact
Total Earnings
18
Avg Abs. Movement
±11.58%
Positive %
38.9%
Negative %
61.1%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| May 07, 2026 | ☽ POST | -13.89% | open_in_new |
| Feb 26, 2026 | ☽ POST | -30.48% | open_in_new |
| Nov 06, 2025 | ☽ POST | -20.8% | open_in_new |
| Aug 07, 2025 | ☽ POST | -8.69% | open_in_new |
Earnings Count
18
Total earnings in dataset
Avg Abs. Movement
±11.58%
Avg % price change on earnings
Institutional ownership
Holdings as of Mar 31, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260720 | open_in_new SEC.gov |
| 144 | 20260717 | open_in_new SEC.gov |
| 4 | 20260615 | open_in_new SEC.gov |
| 4 | 20260615 | open_in_new SEC.gov |
| 4 | 20260615 | open_in_new SEC.gov |
| 4 | 20260615 | open_in_new SEC.gov |
| 8-K | 20260612 | open_in_new SEC.gov |
| 144 | 20260610 | open_in_new SEC.gov |
| 4 | 20260526 | open_in_new SEC.gov |
| 144 | 20260522 | open_in_new SEC.gov |
Frequently asked about DNA earnings
When does Ginkgo Bioworks Holdings, Inc. report earnings next? expand_more
Ginkgo Bioworks Holdings, Inc. (DNA)'s next earnings date is approximate for 2026-08-12. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does DNA stock move after earnings? expand_more
Over 18 reports, DNA has moved an average of ±11.58% the session after earnings, closing higher 38.9% of the time.
What was DNA's biggest post-earnings move? expand_more
DNA's largest post-earnings gain on record was +22.73% on Mar 28, 2022, and its largest decline was -30.48% on Feb 26, 2026.
Where can I find Ginkgo Bioworks Holdings, Inc.'s SEC filings? expand_more
All of Ginkgo Bioworks Holdings, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right